Regardless of possible synergy between Ang II and aldosterone, our results indicate that inhibiting aldosterone synthase alone is sufficient to prevent development and slow progression of cardiac and renal disease in the dTG rat model. This evidence concerns the gene CYP11B2 and kidney disorder.